Ark Therapeutics Group plc today announces the grant
of its patent in the US, Patent Number 6982358, for Kerraboot(R), a novel
woundcare device for the management of leg and foot ulcers. Kerraboot(R) has
already been listed for marketing by the Food and Drug Administration in the US.
